Clinical Trial Update: Dalbavancin For The Treatment of Gram Positive Osteoarticular Infections [Phase 4]

View source ↗

Summary

Phase 4 trial update examining dalbavancin for Gram-positive osteoarticular infections completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Infection
• Osteomyelitis
• Prosthetic Joint Infection
• Septic Arthritis

Drugs mentioned

• Dalbavancin (dalbavancin)

Snippet

Sponsor: Infectious Diseases Physicians, Inc. | Conditions: Bone Infection, Osteomyelitis | Phase 4 | Status: COMPLETED